This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
HSBC (HSBA), Barclays (BARC) - Investors have recovered more than $2bn in settlements with nine banks over claims of price-rigging in the foreign exchange market, and are continuing to pursue claims against seven other banks, a lawyer for the plaintiffs said Thursday. Closing prices 561p, 275.55p. (Reuters)
BP (BP) - A U.S. judge on Thursday found that BP manipulated the natural gas market in 2008, as alleged by the U.S. energy regulator, but did not address a proposed $28m fine or any other penalties. Closing price 383.15p. (Reuters)
Rio Tinto (RIO) - China's Shenhua Group is among six parties assessing bids for Rio Tinto's $4bn thermal coal business, the Australian Financial Review reported on Friday. Closing price 2459p. (Reuters)
Glaxosmithkline (GSK) - Banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result. Closing price 1412.5p. (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Taylor Wimpey | TW | 1.10% | 1.91% | 0.30% |
| Barratt Developments | BDEV | 1.34% | 2.29% | 0.87% |
| Bovis | BVS | 1.62% | 2.13% | 0.77% |
| Persimmon | PSN | 1.12% | 2.05% | 0.10% |
| Bellway | BWY | 1.74% | 2.39% | 0.53% |
| Glencore | GLEN | -1.89% | 4.08% | -2.00% |
| Michael Page International | MPI | 3.70% | 5.12% | 1.52% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research